Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03481881 · ClinicalTrials.gov registry record

Pharmacokinetics of Drugs Administered to Children

A clinical trial of Pediatric ALL, sponsored by Duke University.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT03481881 is a study of Pediatric ALL that is actively recruiting participants, run by Duke University. The registered enrollment target is 200 participants, below the 1,639-participant average among 21 other Pediatric ALL trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03481881, a study of Pediatric ALL, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.

Conditions Studied

Interventions

  • DRUG Standard of care drug

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2013-08-14
Est. Completion 2033-08-14

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03481881

The ClinicalTrials.gov registry entry for NCT03481881 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,639-participant average among 21 other Pediatric ALL trials with a reported enrollment target (88% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pediatric ALL appearing as the primary indexed condition, and to 1 intervention - of which Standard of care drug is the first listed.

NCT03481881 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03481881 about?

NCT03481881 is a clinical study titled "Pharmacokinetics of Drugs Administered to Children". This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.

What is the current status of trial NCT03481881?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2013-08-14. Estimated completion is 2033-08-14.

What conditions does trial NCT03481881 study?

This clinical trial studies the following conditions: Pediatric ALL.

What interventions are being tested in trial NCT03481881?

The interventions under investigation include: Standard of care drug (DRUG).

Who is sponsoring clinical trial NCT03481881?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03481881 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatric ALL

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.